Search for a full or partial Catalog Number, CAS Number or description
CAS Number: 12006-15-4
Product Catalog
48-0150
Cadmium › Cadmium arsenide (99.999%-Cd) PURATREM| CAS Number: | 12006-15-4 |
| MDL Number: | MFCD00049723 |
| Molecular Formula: | Cd3As2 |
| Molecular Weight: | 487.07 |
| Chemical Formula: | Cd3As2 |
| Color and Form: | dark gray solid |
| Note: |
Safety: Hazardous
Physical Characteristics: density 3.031
| SECTION 1: Product Identification | |
|---|---|
| Chemical Name: | Cadmium arsenide (99.999%-Cd) PURATREM |
| Product Number: | 48-0150 |
| CAS Registry Number: | 12006-15-4 |
| Formula: | Cd3As2 |
| EINECS Number: | 234-484-1 |
| Chemical Family: | metal arsenide |
| Synonym: | Cadmium diarsenide |
| SECTION 2: Composition and Information on Ingredients | ||||
|---|---|---|---|---|
| Ingredient | CAS Number | Percent | ACGIH (TWA) | OSHA (PEL) |
| Title compound | 12006-15-4 | 100 | 0.002mg/m3 | 0.005mg/m3 |
| SECTION 3: Hazards Identification | |
|---|---|
| Emergency Overview: | Danger of serious damage to health by prolonged exposure through inhalation and if swallowed. May cause harm to the unborn child. |
| Primary Routes of Exposure: | Ingestion, inhalation, skin, eyes |
| Eye Contact: | May cause mild to severe irritation of the eyes. |
| Skin Contact: | May cause slight to mild irritation of the skin. Harmful in contact with skin. |
| Inhalation: | Harmful by inhalation. Danger of serious damage to health by prolonged exposure through inhalation. |
| Ingestion: | Harmful if swallowed. Ingestion may lead to sudden nausea, vomiting, bloody diarrhea, weakness, convulsions and death. |
| Acute Health Effects: | Inhalation may cause metallic taste, cough, chest pain, fever, shills, pulmonary edema, liver and kidney damage. Ingestion causes garlic breath odor, nausea, vomiting, bloody diarrhea, weakness. . |
| Chronic Health Effects: | Prolonged exposure to cadmium compounds may result in kidney damage, anemia, pulmonary fibrosis, emphysema, perforation of the nasal septum, loss of smell, male reproductive effects and an increased risk of cancer of the lungs, prostate and liver. Prolonged exposure to arsenic compounds may cause loss of appetite, dermatitis, liver and kidney damage, nervous disorders and cancer of the skin, lungs and liver. |
| NTP: | Yes |
| IARC: | Yes |
| OSHA: | Yes |
| SECTION 4: First Aid Measures | |
|---|---|
| Eye Exposure: | Immediately flush the eyes with copious amounts of water for at least 10-15 minutes. A victim may need assistance in keeping their eye lids open. Get immediate medical attention. |
| Skin Exposure: | Wash the affected area with water. Remove contaminated clothes if necessary. Seek medical assistance if irritation persists. |
| Inhalation: | Remove the victim to fresh air. Closely monitor the victim for signs of respiratory problems, such as difficulty in breathing, coughing, wheezing, or pain. In such cases seek immediate medical assistance. |
| Ingestion: | Seek medical attention immediately. Keep the victim calm. Give the victim water (only if conscious). Induce vomiting only if directed by medical personnel. |
| SECTION 5: Fire Fighting Measures | |
|---|---|
| Flash Point: | no data |
| Autoignition Temperature: | no data |
| Explosion Limits: | no data |
| Extinguishing Medium: | carbon dioxide, dry powder or foam |
| Special Fire Fighting Procedures: | If this product is involved in a fire, fire fighters should be equipped with a NIOSH approved positive pressure self-contained breathing apparatus and full protective clothing. |
| Hazardous Combustion and Decomposion Products: | If involved in a fire, this material may emit toxic fumes containing cadmium and arsenic. |
| Unusual Fire or Explosion Hazards: | No unusual fire or explosion hazards. |
| SECTION 6: Accidental Release Measures | |
|---|---|
| Spill and Leak Procedures: | Small spills can be mixed with vermiculite, sodium carbonate or other suitable non-combustible adsorbent and swept up. |
| SECTION 7: Handling and Storage | |
|---|---|
| Handling and Storage: | Store the material in a tightly sealed container under an inert atmosphere of nitrogen or argon. Keep in a cool, dry, well-ventilated place. |
| SECTION 8: Exposure Controls and Personal Protection | |
|---|---|
| Eye Protection: | Always wear approved safety glasses when handling a chemical substance in the laboratory. |
| Skin Protection: | Wear protective clothing and gloves. |
| Ventilation: | Handle the material in an efficient fume hood. |
| Respirator: | If ventilation is not available a respirator should be worn. The use of respirators requires a Respirator Protection Program to be in compliance with 29 CFR 1910.134. |
| Additional Protection: | No additional protection required. |
| SECTION 9: Physical and Chemical Properties | |
|---|---|
| Color and Form: | dark gray solid |
| Molecular Weight: | 487.077 |
| Melting Point: | no data |
| Boiling Point: | no data |
| Vapor Pressure: | no data |
| Specific Gravity: | 3.031 |
| Odor: | none |
| Solubility in Water: | decomposes |
| SECTION 10: Stability and Reactivity | |
|---|---|
| Stability: | moisture sensitive |
| Hazardous Polymerization: | no hazardous polymerization |
| Conditions to Avoid: | prolonged exposure to moisture |
| Incompatibility: | water, acids |
| Decomposition Products: | cadmium oxide, arsenic oxide |
| SECTION 11: Toxicological Information | |
|---|---|
| RTECS Data: | For Cd: Inhalation (human); TCLo: 8630 ug/m3/5H. Inhalation (Human-man); TCLo: 500 ug/m3/5Y-I. Inhalation (Human-man); TCLo: 40 ug/m3. Oral (rat); LD50: 72 mg/kg. Intraperitoneal (rat); LD50: 12 mg/kg. Intravenous (rat); LD50: 25 mg/kg. Oral (mouse); LD50: 72 mg/kg. Inhalation (mouse); LC50:250 mg/m3/2H. Subcutaneous (mouse); LD50: 94 mg/kg. Inhalation (dog); LC50:4 gm/m3/10M. Oral (rat); TDLo: 156 ug/kg/26W-I. Inhalation (rat); TCLo: 23 ug/m3/24H/20W-C. Subcutaneous (rat); TDLo: 90 mg/kg. Oral (rat); TDLo: 21640 ug/kg. Oral (rat); TDLo: 21640 ug/kg. For As: Oral (Human-man); LDLo: 29 mg/kg. Oral (Human-man); LDLo: 286/mg/kg. Oral (Human-man); TDLo: 14857 ug/kg. Oral (Human); LDLo: 1429 ug/kg. Oral (Human-man); LDLo: 2857 mg/kg. Oral (rat); LD50: 14600 ug/kg. Intraperitoneal (rat); LD50: 871 mg/kg. Subcutaneous (rat); LDLo:8 mg/kg. Oral (mouse); LD50: 31500 ug/kg. Subcutaneous (mouse); LD50: 9800 ug/kg. Intravenous (mouse); LD50: 10700 ug/kg. Oral (dog); LDLo: 10 mg/kg. Intravenous (rabbit); LDLo: 10560 ug/kg. Oral (rat); TDLo: 900 mg/kg. Oral (rat); TDLo: 350 ug/kg/30D-I. Inhalation (rat); TCLo: 31 ug/m3/24H/22W-C. Inhalation (rat); TCLo: 500 ug/m3/24H/33D-C. |
| Carcinogenic Effects: | Known carcinogens |
| Mutagenic Effects: | As: mutagen |
| Tetratogenic Effects: | Reproductive effectors |
| SECTION 12: Ecological Information | |
|---|---|
| Ecological Information: | Avoid release into the environment. Very toxic to aquatic organisms. May cause long-term adverse effects in the aquatic environment. |
| SECTION 13: Disposal Considerations | |
|---|---|
| Disposal: | Dispose of according to local, state and federal regulations. |
| SECTION 14: Transportation | |
|---|---|
| Shipping Name (CFR): | Cadmium compounds |
| Hazard Class (CFR): | 6.1 |
| Additional Hazard Class (CFR): | NA |
| Packaging Group (CFR): | III |
| UN ID Number (CFR): | UN# 2570 |
| Shipping Name (IATA): | Cadmium compound |
| Hazard Class (IATA): | 6.1 |
| Additional Hazard Class (IATA): | NA |
| Packaging Group (IATA): | III |
| UN ID Number (IATA): | UN# 2570 |
| SECTION 15: Regulatory Information | |
|---|---|
| TSCA: | Listed in the TSCA inventory |
| SARA (Title 313): | See Category Codes N078 and N020 for reporting. |
| Second Ingredient: | none |
| Third Ingredient: | none |
| SECTION 16: Other Information | |
|---|---|
| Disclaimer: | The information herein is believed to be accurate and reliable as of the date compiled. However, Strem Chemicals, Inc. makes no representation, warranty, or guarantee of any kind with respect to the information contained in this document or any use of the product based on this information. |
| Preparation Date: | 1/19/2011 |
| Revision Date: | 1/19/2011 |
